TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Traws Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.37−0.00 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $5.81M
- P/E (TTM)
- 0.4
- Dividend yield
- –
Dividends
Traws Pharma has not reported a dividend
No dividend per share appears in Traws Pharma's annual filings since fiscal 2010.